{"id":185254,"name":"BRACCO DIAGNOSTICS, INC.","slug":"bracco-diagnostics-inc","state":"NJ","country":"United States of America","description":"company offering diagnostic imaging technology","totalSpending":420000,"filings":18,"yearlySpending":[{"year":2018,"income":40000},{"year":2019,"income":100000},{"year":2020,"income":30000},{"year":2021,"income":50000},{"year":2022,"income":200000},{"year":2023,"income":0}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"CSP","display":"Consumer Issues/Safety/Products"}],"firms":["POLSINELLI PC"],"lobbyists":["MICHAEL GABA","TIMOTHY CASEY","MARK WELLER"],"govEntities":["Centers For Medicare and Medicaid Services (CMS)","HOUSE OF REPRESENTATIVES","SENATE","Food & Drug Administration (FDA)"],"sampleDescriptions":["CY17 CMS HOPPS rule\nHR 4683 To amend title XVIII of the Social Security Act to revise the NTAP period under the Medicare inpatient prospective payment system and the pass-through period under the Medi","Issues relating to FDA compliance matters","Issues relating to FDA compliance matters","Legislation related to FDA compliance matters","H.R. 3772 The Medicare Diagnostic Radiopharmaceutical Equity Act of 2019\nCY 2020 Medicare Physician Fee Schedule Proposed Rule\nLegislation related to Cardiac PFT Imaging"]}